Biopsy, Fine-needle
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Verona PharmaUK - London
2 programsHistologic evaluationN/A1 trial
Rapid on-site evaluationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Verona PharmaHistologic evaluation
Verona PharmaRapid on-site evaluation
Clinical Trials (2)
Total enrollment: 992 patients across 2 trials
EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle
Start: Nov 2018Est. completion: Aug 2020192 patients
N/ACompleted
EUS-FNB With ROSE Vs. EUS-FNB Without ROSE
Start: Mar 2018Est. completion: Jul 2020800 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space